Federal University of Uberlândia
Uberlândia, Minas Gerais, 38405354, Brazil
NCT Number: NCT06731166
The goal of this clinical trial is to measure the effectiveness of video monitoring associated with the transition of care for patients with heart failure.
The main questions it aims to answer is: Is video monitoring superior to monitoring via audio calls in patients with heart failure?
Researchers will compare monitoring by video to a monitoring by audio to see if drug videomonitoring works to improve selfcare in heart failure and other outocomes.
Participants will:
intervention group receive video calls guided by cardiologist nurses at 7, 30, 60, 180 and 365 days after hospital discharge.
the control group will receive audio calls for data collection, at the same time mentioned.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Uberlândia, Minas Gerais, 38405354, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Videomonitoring provide by cardiovascular nurses using motivational interview and teach-back
Time frame: 365 days after discharge
European Self-Care Scale The European self-care scale consists of 12 questions with a single domain related to self-care behavior. Responses to each item range from 1, "I completely agree", to 5, "I completely disagree", following a five-point Likert scale. The total score is obtained by summing all the responses, which can range from 12 to 60. Low values indicate better self-care. The items concern the various self-care behaviors of patients with heart failure, such as checking daily weight (item 1), rest (items 2 and 7), seeking help from the healthcare team (items 3, 4, 5 and 8), fluid restriction (item 6), diet (item 9), medication adherence (item 10), flu vaccination (item 11) and exercise (item 12)
Time frame: 365 days after discharge
Tilburg Frailty Indicator The Tilburg Frailty Indicator (TFI) is a self-report questionnaire that assesses frailty across three domains: physical (8 items), psychological (4 items), and social (3 items). Total scores range from 0 to 15, with higher scores indicating greater frailty. A total score of ≥ 5 is used to classify individuals as frail.
Time frame: 365 days after discharge
Number of death of patients with heart failure during the trial
Time frame: 365 days after discharge
Cardiorespiratory fitness Cardiorespiratory fitness will be assessed by the Veterans Specific Activity Questionnaire (VSAQ), a brief questionnaire that consists of a list of activities presented in a progressive order according to metabolic equivalents (METs). Participants are instructed to determine which activities would cause fatigue, shortness of breath, chest discomfort, or necessity of stopping due to exhaustion if performed for a few minutes. The VSAQ was scored as a whole number (1 to 13 METs) directly from the subject's response. The VSAQ score will be adjusted by age and METs following a regression equation to predict aerobic fitness: METs = 4.7 + 0.97 × VSAQ - 0.06 × age
Time frame: 365 days after discharge
Quality of life in HF patients The quality of life of patients with HF will be assessed by the Minnesota Living with Heart Failure Questionnaire (MLHFQ), a disease-specific questionnaire for patients with HF, comprising 21 items rated on six-point Likert scales representing different degrees of impact of HF on quality of life, from 0 (none) to 5 (very much). It provides a total score (range 0-105, from best to worst quality of life), as well as scores for two dimensions, physical (8 items, range 0-40) and emotional (5 items, range 0-25). The other eight items (a total of 21) are considered only for the calculation of the total score
Time frame: 365 days after discharge
Adherence to HF treatment Adherence to HF treatment will be assessed by an instrument with 10 questions related to the use of prescribed medications, daily weight checks, salt intake, water intake and attendance at scheduled appointments and exams. Each question has 3 to 4 alternatives; for questions with 4 alternatives, the score varied from 0 to 4 points, and for questions with 3 alternatives, the score varied from 0 to 3 points. Therefore, the general adherence score could vary from 0 to 26 points. A minimum score of 18 points will be considered a cutoff point for patients adhering to treatment, corresponding to 70% adherence
Time frame: 365 days after discharge
HF Knowledge Questionnaire The HF knowledge questionnaire consists of 14 questions related to domains such as knowledge of the appropriate diet in HF, knowledge about the amount of fluids ingested and weight control, knowledge about pharmacological and nonpharmacological treatment of HF and general knowledge about the disease. The knowledge score is determined by the sum of the number of correct answers: for the correct question, the patient gains one point, and for each incorrect answer, the patient loses one point. In this way, the score ranges from 0 to 14
Time frame: 365 days after discharge
Number of hospitalization of patients with heart failure during the trial
Federal University of Uberlandia
Other
Acronym: EVIT-HF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07507539
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07332520
Cardiovascular Diseases, Heart Diseases
View Trial DetailsNCT05420012
Cardiovascular Diseases, Heart Diseases
Salt Lake City, Utah, United States
View Trial DetailsNCT05328752
Cardiovascular Diseases, Heart Diseases
Inverness, Florida, United States
View Trial Details